Collegium Pharmaceutical Stock Update After Recent Trading Moves Collegium Pharmaceutical (COLL) has moved within a ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also ...

Fintel reports that on October 28, 2025, Needham reiterated coverage of Collegium Pharmaceutical (NasdaqGS:COLL) with a Buy recommendation. Analyst Price Forecast Suggests 30.67% Upside As of ...

5 analysts have issued ratings. Wall Street analysts rate COLL as Bullish on average, for a Wall Street consensus of buy. View COLL’s ratings here.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...